marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Minerva Neurosciences Balance Sheet 2011-2024 | NERV
Annual Balance Sheet Minerva Neurosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -25.2 M | -21.1 M | -50.2 M | -22.1 M | -74.3 M | -4.35 M | -18.5 M | -1.76 M | -200 K | - |
Long Term Debt |
- | - | - | - | - | - | - | 3.84 M | 8.5 M | - | - | - | - |
Long Term Debt Current |
- | - | - | 111 K | 173 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.8 M | 43.1 M | 45.3 M | 45.3 M | 17.3 M | 21.9 M | 13.4 M | 7.59 M | - | - |
Total Current Liabilities |
3.34 M | 1.38 M | 2.82 M | 3.16 M | 6.63 M | 3.61 M | 6.84 M | 9.69 M | 5.32 M | 3.51 M | - | - | - |
Total Liabilities |
85.4 M | 75.1 M | 69.1 M | 4.96 M | 49.7 M | 48.9 M | 52.1 M | 27 M | 27.3 M | 17 M | 9 M | 190 K | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-397 M | -367 M | -335 M | -285 M | -287 M | -215 M | -164 M | -133 M | -102 M | -74.7 M | -17.8 M | -14.6 M | - |
Total Assets |
56.9 M | 55.1 M | 77.1 M | 57.6 M | 77.5 M | 139 M | 184 M | 133 M | 82.6 M | 68.5 M | 29.2 M | 209 K | - |
Cash and Cash Equivalents |
40.9 M | 36.1 M | 60.8 M | 25.4 M | 21.4 M | 50.2 M | 26.1 M | 83 M | 14.3 M | 18.5 M | 1.82 M | - | - |
Book Value |
-28.5 M | -20 M | 7.98 M | 52.7 M | 27.8 M | 90.3 M | 132 M | 106 M | 55.3 M | 51.5 M | 20.2 M | 19 K | - |
Total Shareholders Equity |
-28.5 M | -20 M | 7.98 M | 52.7 M | 27.8 M | 90.3 M | 132 M | 106 M | 55.3 M | 51.5 M | 20.2 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Minerva Neurosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.3 K | 64.4 K | 111 K | 111 K | 111 K | 111 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.55 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
64.5 M | 90.8 M | 87.1 M | 85.4 M | 83.2 M | 79.6 M | 78.2 M | 75.1 M | 74 M | 73.3 M | 71.4 M | 69.1 M | 69.5 M | 69.2 M | 66.5 M | 4.96 M | 4.96 M | 4.96 M | 4.96 M | 49.7 M | 49.7 M | 49.7 M | 49.7 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 52.1 M | 52.1 M | 52.1 M | 52.1 M | 27 M | 27 M | 27 M | 27 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 17 M | 17 M | 17 M | 17 M | 9 M | 9 M | 9 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-391 M | -414 M | -405 M | -397 M | -388 M | -380 M | -374 M | -367 M | -360 M | -353 M | -344 M | -335 M | -313 M | -304 M | -344 M | -285 M | -285 M | -285 M | -285 M | -287 M | -287 M | -287 M | -287 M | -215 M | -215 M | -215 M | -215 M | -164 M | -164 M | -164 M | -164 M | -133 M | -133 M | -133 M | -133 M | -102 M | -102 M | -102 M | -102 M | -74.7 M | -74.7 M | -74.7 M | -74.7 M | -17.8 M | -17.8 M | -17.8 M | - | - | - | - | - | - | - | - | - |
Total Assets |
42.8 M | 46.3 M | 50.5 M | 56.9 M | 63.1 M | 67.1 M | 51.6 M | 55.1 M | 59.8 M | 65 M | 70.6 M | 77.1 M | 97.6 M | 105 M | 112 M | 57.6 M | 57.6 M | 57.6 M | 57.6 M | 77.5 M | 77.5 M | 77.5 M | 77.5 M | 139 M | 139 M | 139 M | 139 M | 184 M | 184 M | 184 M | 184 M | 133 M | 133 M | 133 M | 133 M | 82.6 M | 82.6 M | 82.6 M | 82.6 M | 68.5 M | 68.5 M | 68.5 M | 68.5 M | 29.2 M | 29.2 M | 29.2 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
26.5 M | 30.9 M | 34.8 M | 40.9 M | 46.9 M | 51.8 M | 36 M | 36.1 M | 40.2 M | 49.8 M | 54.9 M | 60.8 M | 65.6 M | 74.2 M | 80.1 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 50.2 M | 50.2 M | 50.2 M | 50.2 M | 26.1 M | 26.1 M | 26.1 M | 26.1 M | 83 M | 83 M | 83 M | 83 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 1.82 M | 1.82 M | 1.82 M | - | 200 K | - | - | - | - | - | - | - |
Book Value |
-21.7 M | -44.5 M | -36.6 M | -28.5 M | -20 M | -12.5 M | -26.6 M | -20 M | -14.2 M | -8.38 M | -736 K | 7.98 M | 28.1 M | 36.2 M | 45.4 M | 52.7 M | 52.7 M | 52.7 M | 52.7 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 90.3 M | 90.3 M | 90.3 M | 90.3 M | 132 M | 132 M | 132 M | 132 M | 106 M | 106 M | 106 M | 106 M | 55.3 M | 55.3 M | 55.3 M | 55.3 M | 51.5 M | 51.5 M | 51.5 M | 51.5 M | 20.2 M | 20.2 M | 20.2 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-21.7 M | -44.5 M | -36.6 M | -28.5 M | -20 M | -12.5 M | -26.6 M | -20 M | -14.2 M | -8.38 M | -736 K | 7.98 M | 28.1 M | 36.2 M | 45.4 M | 52.7 M | 52.7 M | 52.7 M | 52.7 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 90.3 M | 90.3 M | 90.3 M | 90.3 M | 132 M | 132 M | 132 M | 132 M | 106 M | 106 M | 106 M | 106 M | 55.3 M | 55.3 M | 55.3 M | 55.3 M | 51.5 M | 51.5 M | 51.5 M | 51.5 M | 20.2 M | 20.2 M | 20.2 M | - | 19 K | - | - | - | - | - | - | - |
All numbers in USD currency